Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia
Clinical trial NCT03433755 · TERMINATED
Trial details
- NCT number
- NCT03433755
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-09
- Primary completion
- 2020-04-24
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.